- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06481631
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
Empowering Women for Postpartum Care and Reproductive Health in Mississippi Delta
Maternal mortality in the United States is higher than in peer nations and has not decreased since 1990. Beyond mortality, severe maternal mortality impacts far too many women. Not only are these high rates alarming, but notable racial/ethnic and socioeconomic disparities exist. These inequities are highly regional, with women living in the rural southeast part of the United States, including the Mississippi Delta, having the highest rates of maternal mortality and morbidity. Unfortunately, these disparities have proven to be stubbornly resistant to interventions, necessitating an innovative multifaceted approach focused on community practice, building trust, and prioritizing patient voices. To meet this need, this proposal aims to establish the Mississippi Delta Research Center of Excellence for Maternal Health with the goal of addressing preventable maternal mortality, decreasing severe maternal morbidity, and promoting maternal health equity in partnership with the Mississippi Delta community. This patient-clinical linkages intervention study will evaluate the effectiveness of a multilevel and multisector communication and health literacy strategy to increase trust and engagement in postpartum healthcare among women in the Mississippi Delta, with a specific focus on Black women, their families, and their communities.
These research projects both have the overarching goal of partnering with the community to determine and meet the needs of pregnant and postpartum women in the Mississippi Delta and address the disparities within maternity health and health care outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mary Shaw, PhD
- Phone Number: 601-979-3103
- Email: mary.shaw@jsums.edu
Study Contact Backup
- Name: Girmay Berhie, PhD
- Phone Number: 601-979-1184
- Email: girmay.berhie@jsums.edu
Study Locations
-
-
Mississippi
-
Jackson, Mississippi, United States, 39213
- Recruiting
- Jackson State University/Department of Behavioral & Environmental Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Identified as high risk pregnancy
- Postpartum mothers/parents 18-45 years
- Resident of the one of 5 target counties (Washington, Bolivar, Scott, Humphreys, and Carroll)
- Maternal healthcare providers in target counties
- Maternal community health leaders
Exclusion Criteria:
- not identified as high risk pregnancy
- 18 years of age postpartum
- cesarean birth
- non-resident of the 5 target counties
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: PEN-3 Assessment Model
Application of a sociocultural model to assess patient-clinical linkages that support positive maternal health outcomes
|
The PEN-3 Model is a sociocultural model for planning and assessing participant behavior within the context a cultural phenomenon.
It will be used to assess intervention impact on patient-clinical linkages in the Mississippi Delta.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improve trust in the healthcare system
Time Frame: 12 months from consent to participate
|
Mixed methods approach using Trust in Physician Scale & Researcher developed qualitative tool
|
12 months from consent to participate
|
|
Increase maternal health literacy (patient and provider perspectives)
Time Frame: 12 months from consent to participate in the intervention
|
Brief literacy screening tool to evaluate health literacy in the health system (Qualitative and Quantitative Measures
|
12 months from consent to participate in the intervention
|
|
Increase engagement in the maternal health care system (patient-clinic linkages)
Time Frame: 12 month from consent to participation in the intervention
|
Contraceptive Counseling measure tool to evaluate the patient experiences with provider care and vice-versa; minimally 2 post-partum clinec visits in postpartum period
|
12 month from consent to participation in the intervention
|
|
Strengthen structuring of family support systems
Time Frame: 12 months from consent to participation in the intervention
|
Family crisis coping response (F-COPES) measure to determine patient (mother) and family perceptions and experiences with structuring family support fo postpartum care period.
|
12 months from consent to participation in the intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mary Shaw, PhD, Jackson State University
- Study Director: Mary Shaw, PHD, M.ED, Jackson State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1U54HD113238-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Montefiore Medical CenterSociety of Family PlanningCompletedContraception | Breastfeeding | Postpartum ContraceptionUnited States
Clinical Trials on The PEN-3 Intervention Model
-
Jackson State UniversityHarvard School of Public Health (HSPH); University of Mississippi Medical Center and other collaboratorsRecruitingMaternal Behavior | Postpartum Mood DisturbanceUnited States
-
Ariel UniversityMaccabi Healthcare Services, IsraelCompleted
-
Universiti Sains MalaysiaCompleted
-
Boston UniversityCompleted
-
TC Erciyes UniversityCompletedChronic Obstructive Pulmonary Disease | Self EfficacyTurkey
-
Jimma UniversityCompletedHIV/AIDS | Unintended Pregnancy | Sexually Transmitted Infections(STIs)Ethiopia
-
King Saud UniversityCompletedHealth Literacy | Fall Prevention | Chronic Stroke Patients | Education of Patients | Health Belief ModelSaudi Arabia
-
EchosensCompletedObesity, Morbid | Liver FibrosisFrance
-
Hospital da Luz, PortugalUniversidade Católica PortuguesaCompletedAged | Patient Outcome Assessment | MultimorbidityPortugal